An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon Receptor-Interacting protein (AIP) gene

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 4, 2011, Pages 431-439

  Craig Rowlands, J ^a   Urban, Jonathan D ^b   Wikoff, Daniele Staskal ^b   Budinsky, Robert A ^a  

^a DOW CHEMICAL COMPANY   (United States)

^b ToxStrategies   (United States)

Author keywords

Ah receptor interacting protein; Human genetics; Polychlorinated dibenzo p dioxins; Single nucleotide polymorphism; TCDD

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; GENOMIC DNA; PEPTIDYLPROLYL ISOMERASE; POLYCHLORINATED DIBENZODIOXIN; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN GENE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC DIFFERENCE; ETHNICITY; EXON; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPOPHYSIS TUMOR; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROMOTER REGION; PROTEIN DOMAIN; RECEPTOR GENE; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80052580445     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-SC-013     Document Type: Article

References (29)

1. Bell, D. R. and Poland, A.: Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein. The role of hsp90. J. Biol. Chem., 275: 36407-36414 (2000).
2. Lees, M. J., Peet, D. J. and Whitelaw, M. L.: Defining the role for XAP2 in stabilization of the dioxin receptor. J. Biol. Chem., 278: 35878-35888 (2003).
3. LaPres, J. J., Glover, E., Dunham, E. E., Bunger, M. K. and Bradfield, C. A.: ARA9 modifies agonist signaling through an increase in cytosolic aryl hydrocarbon receptor. J. Biol. Chem., 275: 6153-6159 (2000).
4. Meyer, B. K. and Perdew, G. H.: Characterization of the AhRhsp90- XAP2 core complex and the role of the immunophilinrelated protein XAP2 in AhR stabilization. Biochemistry, 38: 8907-8917 (1999).
5. Petrulis, J. R., Hord, N. G. and Perdew, G. H.: Subcellular localization of the aryl hydrocarbon receptor is modulated by the immunophilin homolog hepatitis B virus X-associated protein 2. J. Biol. Chem., 275: 37448-37453 (2000).
6. Bolger, G. B., Peden, A. H., Steele, M. R., MacKenzie, C., McEwan, D. G., Wallace, D. A., Huston, E., Baillie, G. S. and Houslay, M. D.: Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J. Biol. Chem., 278: 33351-33363 (2003).
7. de Oliveira, S. K., Hoffmeister, M., Gambaryan, S., Muller-Esterl, W., Guimaraes, J. A. and Smolenski, A. P.: Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. J. Biol. Chem., 282: 13656-13663 (2007).
8. Kang, B. H. and Altieri, D. C.: Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J. Biol. Chem., 281: 24721-24727 (2006).
9. Dull, A. B., Carlson, D. B., Petrulis, J. R. and Perdew, G. H.: Characterization of the phosphorylation status of the hepatitis B virus X-associated protein 2. Arch. Biochem. Biophys., 406: 209-221 (2002).
10. Lahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K. and Bradfield, C. A.: The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol., 67: 714-720 (2005).
11. Lin, B. C., Sullivan, R., Lee, Y., Moran, S., Glover, E. and Bradfield, C. A.: Deletion of the aryl hydrocarbon receptorassociated protein 9 leads to cardiac malformation and embryonic lethality. J. Biol. Chem., 282: 35924-35932 (2007).
12. Lin, B. C., Nguyen, L. P., Walisser, J. A. and Bradfield, C. A.: A hypomorphic allele of aryl hydrocarbon receptor-associated protein-9 produces a phenocopy of the AHR-null mouse. Mol. Pharmacol., 74: 1367-1371 (2008).
13. Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M., Salmela, P. I., Paschke, R., Gundogdu, S., De Menis, E., Makinen, M. J., Launonen, V., Karhu, A. and Aaltonen, L. A.: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science, 312: 1228-1230 (2006).
14. Daly, A. F., Vanbellinghen, J. F., Khoo, S. K., Jaffrain-Rea, M. L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez- Roqueplo, A. P., Tamburrano, G., Raverot, G., Barlier, A., De Herder, W., Penfornis, A., Ciccarelli, E., Estour, B., Lecomte, P., Gatta, B., Chabre, O., Sabate, M. I., Bertagna, X., Garcia Basavilbaso, N., Stalldecker, G., Colao, A., Ferolla, P., Wemeau, J. L., Caron, P., Sadoul, J. L., Oneto, A., Archambeaud, F., Calender, A., Sinilnikova, O., Montanana, C. F., Cavagnini, F., Hana, V., Solano, A., Delettieres, D., Luccio-Camelo, D. C., Basso, A., Rohmer, V., Brue, T., Bours, V., Teh, B. T. and Beckers, A.: Aryl hydrocarbon receptorinteracting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J. Clin. Endocrinol. Metab., 92: 1891-1896 (2007).
15. Leontiou, C. A., Gueorguiev, M., van der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H. S., Igreja, S. C., Jordan, S., Rowe, J., Stolbrink, M., Christian, H. C., Wray, J., Bishop-Bailey, D., Berney, D. M., Wass, J. A., Popovic, V., Ribeiro-Oliveira, A., Jr., Gadelha, M. R., Monson, J. P., Akker, S. A., Davis, J. R., Clayton, R. N., Yoshimoto, K., Iwata, T., Matsuno, A., Eguchi, K., Musat, M., Flanagan, D., Peters, G., Bolger, G. B., Chapple, J. P., Frohman, L. A., Grossman, A. B. and Korbonits, M.: The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J. Clin. Endocrinol. Metab., 93: 2390-2401 (2008).
16. Georgitsi, M., Karhu, A., Winqvist, R., Visakorpi, T., Waltering, K., Vahteristo, P., Launonen, V. and Aaltonen, L. A.: Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. Br. J. Cancer, 96: 352-356 (2007).
17. Micka, J., Milatovich, A., Menon, A., Grabowski, G. A., Puga, A. and Nebert, D. W.: Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics, 7: 95-101 (1997).
18. Rowlands, C. J., Staskal, D. F., Gollapudi, B. and Budinsky, R.: The human AHR: identification of single nucleotide polymorphisms from six ethnic populations. Pharmacogenet. Genomics, 20: 283-290 (2010).
19. Harper, P. A., Wong, J. Y., Lam, M. S. and Okey, A. B.: Polymorphisms in the human AH receptor. Chem. Biol. Interact., 141: 161-187 (2002).
20. Celius, T. and Matthews, J.: Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology, 277: 59-65 (2010).
21. Coassin, S., Brandstätter, A. and Kronenberg, F.: Lost in the space of bioinformatic tools: a constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox. Atherosclerosis, 209: 321-335 (2010).
22. Yuan, H. Y., Chiou, J. J., Tseng, W. H., Liu, C. H., Liu, C. K., Lin, Y. J., Wang, H. H., Yao, A., Chen, Y. T. and Hsu, C. N.: FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res., 34: W635-41 (2006).
23. Desmet, F. O., Hamroun, D., Lalande, M., Collod-Béroud, G., Claustres, M. and Béroud, C.: Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res., 37: e67 (2009).
24. Igreja, S., Chahal, H. S., King, P., Bolger, G. B., Srirangalingam, U., Guasti, L., Chapple, J. P., Trivellin, G., Gueorguiev, M., Guegan, K., Stals, K., Khoo, B., Kumar, A. V., Ellard, S., Grossman, A. B. and Korbonits, M.: the International FIPA Consortium: Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum. Mutat., 31: 950-960 (2010).
25. Nukaya, M., Lin, B. C., Glover, E., Moran, S. M., Kennedy, G. D. and Bradfield, C. A.: The aryl hydrocarbon receptor- interacting protein (AIP) is required for dioxin-induced hepatotoxicity but not for the induction of the Cyp1a1 and Cyp1a2 genes. J. Biol. Chem., 285: 35599-35605 (2010).
26. Kasuki Jomori de Pinho, L., Vieira Neto, L., Armondi Wildemberg, L. E., Gasparetto, E. L., Marcondes, J., de Almeida Nunes, B., Takiya, C. M. and Gadelha, M. R.: Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53. Neuroendocrinology. Electronically published ahead of print on Dec 18, 2010. doi:10.1159/000322787.
27. Georgitsi, M., Raitila, A., Karhu, A., Tuppurainen, K., Makinen, M. J., Vierimaa, O., Paschke, R., Saeger, W., van der Luijt, R. B., Sane, T., Robledo, M., De Menis, E., Weil, R. J., Wasik, A., Zielinski, G., Lucewicz, O., Lubinski, J., Launonen, V., Vahteristo, P. and Aaltonen, L. A.: Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptorinteracting protein gene mutations. Proc. Natl. Acad. Sci. USA, 104: 4101-4105 (2007).
28. Carver, L. A. and Bradfield, C. A.: Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J. Biol. Chem., 272: 11452-11456 (1997).
29. Carver, L. A., LaPres, J. J., Jain, S., Dunham, E. E. and Bradfield, C. A.: Characterization of the Ah receptor-associated protein, ARA9. J. Biol. Chem., 273: 33580-33587 (1998).